Patent prompts Rochester to sue for slice of drug profits.
Malakoff
D
D
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use; D000068579:Celecoxib; D003001:Cloning, Molecular; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000191:economics / Q000627:therapeutic use; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000235:genetics; D007783:Lactones / Q000191:economics / Q000627:therapeutic use; D008565:Membrane Proteins; D009518:New York; D010330:Patents as Topic; D011451:Prostaglandin-Endoperoxide Synthases / Q000235:genetics; D011720:Pyrazoles; D013449:Sulfonamides / Q000191:economics / Q000627:therapeutic use; D013450:Sulfones; D014481:United States; D014495:Universities / Q000191:economics / Q000331:legislation & jurisprudence*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007783:Lactones; D008565:Membrane Proteins; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D000068579:Celecoxib